Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Bariatric Surgery, Semaglutide Once Weekly, and Tirzepatide Once Weekly in Patients With Obesity

NCT06803888 is registered in ClinicalTrials.gov with Ali Aminian as lead sponsor.

NCT NCT06803888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06803888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Bariatric Surgery, Semaglutide Once Weekly, and Tirzepatide Once Weekly in Patients With Obesity
Lead sponsor
Ali Aminian
Phase
Phase 4
Overall status
Active, not recruiting
Start date
January 29, 2025
Completion date
December 1, 2027
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity and obesity-related medical conditions